Related Experiment Video
Updated: May 30, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
What can be done to reduce mortality from paracetamol overdoses? A patient interview study
1Centre for Suicide Research, University of Oxford, Department of Psychiatry, Warneford Hospital, Headington, Oxford, OX3 7JX, UK.
QJM : Monthly Journal of the Association of Physicians
|August 23, 2011
Summary
Large paracetamol overdoses are common, with many patients young, female, and having overdosed previously. Easy availability and media influence contribute to fatalities, necessitating stricter sales guidelines.
Area of Science:
- Toxicology
- Public Health
- Pharmacovigilance
Background:
- Paracetamol (acetaminophen) is a leading cause of fatal hepatotoxicity and self-poisoning in the UK.
- Despite legislation limiting pack sizes, over 100 deaths annually persist, with evidence of sales guideline breaches.
- The study addresses the ongoing public health concern of paracetamol-related mortality and morbidity.
Purpose of the Study:
- To investigate the characteristics of individuals ingesting large paracetamol (acetaminophen) overdoses.
- To assess compliance with sales guidelines for paracetamol (acetaminophen) purchases.
- To inform strategies for reducing paracetamol-related fatalities.
Main Methods:
- An interview-based study was conducted with 60 general hospital patients.
- Participants had ingested overdoses exceeding 16 paracetamol (acetaminophen) tablets (8 g).
Main Results:
- Half of overdoses involved more than 16 tablets; patients were predominantly young (16-40 years) and female.
- Over half had a history of paracetamol overdose, and three-quarters expressed suicidal intent.
- Paracetamol (acetaminophen) was chosen for its availability and low cost, with media and internet influences noted.
Conclusions:
- Further measures are needed to enforce sales guidelines and mitigate paracetamol (acetaminophen) overdose risks.
- Media and internet platforms should adhere to responsible reporting guidelines for suicide.
- Addressing patient access and understanding of risks is crucial for reducing fatalities.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:14Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...